Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Loss of heterozygosity of chromosome 13q33-34 region and molecular analysis of ING1 and p53 genes in bladder carcinoma.

Molecular biology reports - 1 Feb 2015

Igci Mehri, Arslan Ahmet, Erturhan Sakip, Igci Yusuf Ziya, Pala Elif, Gogebakan Bulent, Karakok Metin, Cakmak Ecir Ali, Cengiz Beyhan

Abstract excerpt

Cancer is a consequence of accumulation of genetic and epigenetic alterations in the cell which can lead to activation of oncogenes or inactivation of tumor suppressor genes (TSG). Since members of ING family were discovered as TSGs in different cancer types, it was aimed to analyze the chromosom...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Chromosomes, Human, Pair 13
Share to Genes, p53

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Loss of Heterozygosity

Share to Physical Chromosome Mapping

Share to Response Elements

Share to Tumor Suppressor Proteins

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 25324173
DOI: 10.1007/s11033-014-3794-1

Genes

ING1
BPTF
SOX1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25324173-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Loss of heterozygosity of chromosome 13q33-34 region and molecular analysis of ING1 and p53 genes in bladder carcinoma.PMID 25324173Read ↗

Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.Semantic proximity Read ↗

The candidate tumour suppressor gene, ING1, is retained in colorectal carcinomas.Semantic proximity Read ↗

Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ.Semantic proximity Read ↗

Cloning of a novel gene (ING1L) homologous to ING1, a candidate tumor suppressorSemantic proximity Read ↗

Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma.Semantic proximity Read ↗

[Mutation, loss of heterozygosity, and expression of tumor suppressor gene ING1 in sporadic colorectal carcinoma].Semantic proximity Read ↗

An integrated genomic, transcriptional and protein investigation of FGFRL1 as a putative 4p16.3 deletion target in bladder cancer.Semantic proximity Read ↗

Evidence for alternative candidate genes near RB1 involved in clonal expansion of in situ urothelial neoplasia.Semantic proximity Read ↗

Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.Semantic proximity Read ↗

[Some molecular-genetic markers, defining the pathogenesis of superficial and invasive bladder cancer].Semantic proximity Read ↗

Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.